Skip to main content

VIEW OUR UPCOMING VIRTUAL & IN-PERSON EVENTS

small background image large background image

The Trial Ends. The TMF Obligation Doesn’t.

Once a study closes, the sponsor still has to keep its Trial Master File (TMF) complete, legible, and inspection-ready for decades. Here’s how three biotechs moved closed and legacy TMFs into a compliant environment with Trial Interactive without losing a single audit trail.

Results at a glance

~2 million legacy documents

Migrated in 3–6 months

Every document’s metadata

And audit trail preserved through migration

Minimal findings

In a full mock inspection after migration

25 Years Is a Long Time to Keep a File Inspection-Ready

In the EU, the Clinical Trials Regulation (Regulation (EU) No 536/2014, Article 58) sets clear expectations for the TMF after a trial ends. The sponsor must:
• Retain the TMF for at least 25 years after the end of the trial, unless other EU legislation requires a longer period
• Keep it readily available and accessible to competent authorities upon request
• Document any transfer of ownership of the TMF content
• Restrict access to named individuals responsible for the archive
• Maintain complete and legible content throughout the retention period
• Ensure every change is traceable
Where it goes wrong: At study close, the TMF often resides in a system the sponsor doesn’t control, such as a service provider’s eTMF, unstructured file shares, or multiple CRO systems with different naming conventions. Moving it into a compliant, sponsor-controlled archive while preserving metadata and audit trails presents a significant challenge.

What a Good Migration Protects

• The audit trail travels with the document. Vesper Bio preserved metadata integrity and the audit trail for every document, so the archive shows how the TMF was built, not just what’s in it.
• Quality is checked before it’s locked. iOnctura conducted end-of-study quality reviews, while Vesper Bio had sponsor-level documents reconciled to identify gaps before archiving.
• Structure goes in, so records come out. Akebia mapped inconsistent naming conventions to the TMF Reference Model. iOnctura moved unstructured folders into a centralized environment.
• The sponsor keeps the keys. Each company now has its TMF in a sponsor-controlled environment, with direct access to search for and retrieve records.
• Inspection readiness outlasts the study. A well-migrated TMF can withstand scrutiny long after a trial ends, as Akebia’s mock inspection demonstrated.

Migration Expertise and Long-Term Archiving from One Partner

Trial Interactive combines TMF migration, quality review, and secure long-term archiving. Your TMF moves once, arrives complete, and stays inspection-ready throughout the retention period.

  • Archive from any source: Store documents from Trial Interactive or third-party eTMFs

  • Built for the long term: Records retained in accessible long-term formats, including PDF/A and flat files, for 25+ years

  • Audit-ready throughout: Audit trail reporting, integrity and checksum verification, and annual backup and recovery reports

  • Controlled access: Access for administrative staff, designated archivists, and regulatory inspectors as needed

  • Storage that fits the study’s stage: Live System for closeout and early inspections, Active Archive for recently closed studies, and Passive Archive for cold storage

  • Managed for you: Archives managed by TransPerfect service personnel and an archivist


Compliant, Inspection-Ready Archiving for the Long Term

A study’s TMF has to stay complete and inspection-ready for decades after the trial closes. See how Vesper Bio, iOnctura, and Akebia Therapeutics moved closed and legacy TMFs into a compliant, sponsor-controlled archive, with metadata and audit trails intact.